Journal of Virology & Antiviral Research (JVAR)

Journal of Virology & Antiviral Research publishes original contributions from all sections on the virus, virus-like agents, viral infections of humans, animals, plants and bacteria along with antiviral research studies. It covers the wide range of topics related to newly discovered viruses, studies on viral structure and studies of virus interactions with host cells, organisms and populations. Journal of Virology & Antiviral Research features article on all aspects of viral structure and viral types, viral immunological studies like host-virus interaction, host defenses, replication and maturation studies of virus etc and different types of viral-associated diseases, viral oncology studies antiviral studies on both cancer causing diseases and normal viral diseases special references to HIV, hepatitis virus along with Antiviral drugs studies on validation, immunology impacts on the host and present scenario on viral structure, viral genetic, emergence of different types of viruses in the present scenario. The journal follows double-blind peer review process and first initial review within 21 days from the date of submission of the manuscript. Manuscripts submitted by authors will be evaluated through Editorial Tracking System by Editors & reviewers of particular expertise in the same field to ensure that the published articles are of high quality with accurate and reliable information & data, which reflect solid scholarship. Editors can manage the whole submission, review, revision and publishing process, however at least two independent reviewer's approval followed by the Editor decision is required for the acceptance of any citable manuscript.

Journal of Virology & Antiviral Research (JVAR) is :-

• International, Peer-Reviewed, Open Access, Refereed, Virology, Antiviral Research, Viral Immunology, Viral Oncology, Host-Pathogen Interactions, Viral Genetics, Antiviral Drug Development , Online , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2324-8955, Established: 2012, Impact Factor: 2.54
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE